mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |